NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Crypto stocks surge as Bitcoin short squeeze hits record $2.7B
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
NovaBay Pharma (NBY) Misses Q1 EPS by 6c
May 10, 2018 4:21 PM EDTNovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.14), $0.06 worse than the analyst estimate of ($0.08).
In combination with the salesforce reduction at the end of 2017, we paused our planned salesforce expansion in a seasonally slow revenue quarter to focus on identifying the most profitable territories, said Mark M. Sieczkarek, NovaBays Chairman, President and CEO. Although... More
